Got 2 key approvals in 2 weeks: Anuh Pharma
The shares of Anuh Pharma have risen about 200% in the last one year. The management says that they have got 2 key regulatory approvals for their products in the last 2 weeks, and hence, business outlook appears strong. Speaking to ET Now, Bipin Shah, MD, Anuh Pharma says that the company has charted out its growth chart for the next 5-6 years, and it hopes to achieve a topline of 800 crore by 2021.
Read more on
03:54
00:54
01:02
01:38
01:46
01:26
02:03
06:42
03:05
01:17
02:14
02:28
TATAs sign deal to buy 65% stake in 1MG
Views: 155100:59
01:32
01:05
02:42
02:36
01:34
02:07
02:58
02:42
03:08
02:39
02:00
01:59
00:37
02:43
01:55
01:15
18:48
01:07
02:38
01:02
01:28
01:36
01:14
07:17
03:54
03:34
03:20